ArticleBMC cancer2012

The predictive value of microRNA-126 in relation to first line treatment with capecitabine and oxaliplatin in patients with metastatic colorectal cancer.

Torben Frøstrup Hansen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.